BSECompany Update11 Aug 2026 · 11 Aug 2026, 06:03 pm

Press Release regarding Financial Results of the Company for the quarter ended June 30, 2026, along with the declaration of dividend at the rate of 10% i.e. Rs. 1/- per Equity Share.

Prevest Denpro Ltd · 543363

✦ AI Summary▲ PositiveResults

Prevest Denpro Ltd reported strong Q1 FY 2026-27 performance with 20.94% YoY revenue growth and 27.99% YoY PAT rise. The company declared a 10% dividend at ₹1 per equity share.

Analysis Scores

Earnings Impact8/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact9/10
Market Sentiment9/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Prevest Denpro Ltd - 543363 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Attachments (1)

📄

5a028935-ae2c-49f9-a732-17b7f90978a5.pdf

pdf

Download →
View document text
August 11, 2026 BSE Limited, Corporate Relationship Department, P.J. Towers, Dalal Street, Mumbai 400 001 Scrip No. 543363 Sub: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)- Press Release. Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Press Release regarding the Financial Results of the Company for the quarter ended June 30, 2026, along with the declaration of dividend at the rate of 10%, i.e., ₹1/- per equity share. We request you to take the same on your record. Thanking You, Yours faithfully, For Prevest Denpro Limited Pratul Gupta Company Secretary & Compliance Officer Encl: As above PRESS RELEASE Prevest Denpro Limited Reports Strong Q1 FY 2026–27 Performance Revenue from Operations grows 20.94% YoY and Consolidated PAT rises 27.99% YoY Jammu, August 11, 2026 – Prevest Denpro Limited, a leading dental products company, today announced its financial results for the quarter ended June 30, 2026. The Company delivered strong growth across key financial parameters, supported by continued business momentum and sustained demand across its product portfolio. Note: All financial figures are stated in ₹ Lakhs, unless otherwise indicated. MANAGEMENT COMMENTARY “We are pleased to begin FY 2026-27 on a strong note, delivering healthy double-digit growth across our key financial parameters. Our consolidated Revenue from Operations grew 20.94% year-on-year, while EBITDA, PBT and PAT increased by 24.73%, 26.23% and 27.99%, respectively. The performance reflects the continued strength of our business fundamentals, growing acceptance of our dental product portfolio and our focus on operational efficiency. We remain committed to expanding our product offerings, strengthening our domestic and international presence and creating sustainable long-term value for our stakeholders. We remain optimistic about the year ahead and focused on driving sustainable growth through continued innovation, product development, operational excellence and expansion across domestic and international markets.” — Mr. Atul Modi, Chairman and Managing Director KEY FINANCIAL HIGHLIGHTS Standalone Results ● Revenue from Operations: grew 23.66% YoY to ₹1,944.33 lakh, compared to ₹1,572.27 lakh in Q1 FY 2025-26, and increased 2.85% QoQ from ₹1,890.40 lakh ● Total Income: grew 22.96% YoY to ₹2,077.40 lakh, compared to ₹1,689.53 lakh in Q1 FY 2025-26, and increased 2.00% QoQ from ₹2,036.66 lakh ● EBITDA: grew 22.60% YoY to ₹821.88 lakh, compared to ₹670.40 lakh in Q1 FY 2025-26 ● PBT: grew 23.96% YoY to ₹770.26 lakh, compared to ₹621.38 lakh in Q1 FY 2025-26 ● PAT: grew 24.77% YoY to ₹578.23 lakh, compared to ₹463.42 lakh in Q1 FY 2025-26 Consolidated Results ● Revenue from Operations: grew 20.94% YoY to ₹1,906.83 lakh, compared to ₹1,576.63 lakh in Q1 FY 2025-26, and increased 0.67% QoQ from ₹1,894.06 lakh ● Total Income: grew 20.38% YoY to ₹2,038.36 lakh, compared to ₹1,693.24 lakh in Q1 FY 2025-26, and increased 0.18% QoQ from ₹2,034.67 lakh ● EBITDA: grew 24.73% YoY to ₹808.14 lakh, compared to ₹647.93 lakh in Q1 FY 2025-26 ● PBT: grew 26.23% YoY to ₹755.89 lakh, compared to ₹598.82 lakh in Q1 FY 2025-26 ● PAT: grew 27.99% YoY to ₹563.86 lakh, compared to ₹440.54 lakh in Q1 FY 2025-26 DIVIDEND DECLARATION ● The Board of Directors has recommended a dividend of 10% (₹1 per equity share) for FY 2025-26, subject to shareholder approval, as applicable. ABOUT PREVEST DENPRO LIMITED Prevest Denpro Limited is a leading manufacturer of dental materials and products, offering a comprehensive portfolio of dental solutions across restorative dentistry, endodontics, adhesives and bonding agents, preventive care, prosthodontics and other segments. With a focus on innovation, quality and product development, the Company serves dental professionals across domestic and international markets. Prevest Denpro Limited | Jammu, India This press release is for informational purposes and contains forward-looking statements subject to risks and uncertainties.